Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
0.9826
-0.0011 (-0.11%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Unity Biotechnology Employees
Unity Biotechnology had 16 employees as of December 31, 2024. The number of employees decreased by 3 or -15.79% compared to the previous year.
Employees
16
Change (1Y)
-3
Growth (1Y)
-15.79%
Revenue / Employee
n/a
Profits / Employee
-$1,718,875
Market Cap
16.82M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
UBX News
- 3 days ago - UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 4 weeks ago - Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls - Benzinga
- 4 weeks ago - UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema - GlobeNewsWire
- 4 weeks ago - UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 - GlobeNewsWire
- 7 weeks ago - UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 3 months ago - UNITY Biotechnology Reports Granting of New Employment Inducement Award - GlobeNewsWire
- 3 months ago - UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire
- 6 months ago - UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire